Location History:
- Boston, MA (US) (2005 - 2008)
- Cambridge, MA (US) (2008 - 2023)
- Billerica, MA (US) (2024)
Company Filing History:
22 out of 2,943 
6 out of 141 
6 out of 424 
Years Active: 2005-2024
Title: Nadia Brugger - Innovator in Pharmaceutical Chemistry
Introduction
Nadia Brugger is a notable inventor based in Cambridge, MA, whose contributions to pharmaceutical chemistry have led to the successful patenting of 32 innovative compounds. Her work primarily focuses on the development of specialized inhibitors and antagonists that hold significant potential in therapeutic applications.
Latest Patents
Among Nadia's latest patents are:
1. **Substituted pyrazoles as type II IRAK inhibitors** - This invention relates to compounds of Formula I and their pharmaceutically acceptable compositions, which are useful as IRAK inhibitors.
2. **TLR7/8 antagonists and uses thereof** - This patent involves compounds of Formula 1 and their pharmaceutically acceptable compositions, intended to function as TLR7/8 antagonists.
Career Highlights
Nadia has held positions at several prestigious organizations throughout her career, including Merck Patent GmbH and Sigma-Aldrich Co. LLC. Her work in these companies has significantly influenced the field of drug development, showcasing her dedication to advancing medical science through innovative therapeutic solutions.
Collaborations
Throughout her career, Nadia has collaborated with renowned professionals such as Brian A Sherer and Theresa L Johnson. These partnerships have fostered a productive environment, facilitating the innovation process and enhancing the development of new compounds.
Conclusion
Nadia Brugger's innovative spirit and dedication to her work have established her as a pioneering figure in pharmaceutical chemistry. With her impressive portfolio of patents and successful collaborations, she continues to make significant strides in the field, promising advancements that could transform therapeutic practices.